{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:14:40Z","timestamp":1751429680944,"version":"3.41.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07665-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:51:39Z","timestamp":1751381499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated serum CA72-4 as a novel diagnostic biomarker for acute gout flares"],"prefix":"10.1038","volume":"15","author":[{"given":"Yong","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinna","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"11","key":"7665_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo, C. F. et al. Global epidemiology of gout: prevalence, incidence and risk factors. Nat. Rev. Rheumatol. 11 (11), 649\u2013662 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"7665_CR2","unstructured":"Chinese Society of Rheumatology, Chinese Medical Association. Chinese gout diagnosis and treatment guidelines. Chin. J.  Internal Med. 55 (11), 892\u2013899. (2016)."},{"issue":"1","key":"7665_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13075-020-02244-6","volume":"22","author":"D Vedder","year":"2020","unstructured":"Vedder, D. et al. Neutrophil activation identifies patients with active polyarticular gout. Arthritis Res. Ther. 22 (1), 148 (2020).","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"7665_CR4","first-page":"3649","volume":"37","author":"AI Mariampillai","year":"2017","unstructured":"Mariampillai, A. I. et al. Cancer antigen 72\u2009\u2013\u20094 for the monitoring of advanced tumors of the Gastrointestinal tract, lung, breast and ovaries. Anticancer Res. 37 (7), 3649\u20133656 (2017).","journal-title":"Anticancer Res."},{"issue":"6","key":"7665_CR5","first-page":"446","volume":"36","author":"W Schmiegel","year":"1989","unstructured":"Schmiegel, W. Tumor markers in pancreatic cancer\u2013current concepts. Hepatogastroenterology 36 (6), 446\u2013449 (1989).","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"7665_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1742-1241.2007.01614.x","volume":"64","author":"H Demirci","year":"2010","unstructured":"Demirci, H. et al. CA 72\u2009\u2013\u20094 levels in patients with type 2 diabetes mellitus. Int. J. Clin. Pract. 64 (1), 34\u201338 (2010).","journal-title":"Int. J. Clin. Pract."},{"key":"7665_CR7","unstructured":"Carpelan-Holmstr\u00f6m, M. et al. CEA, CA 19\u2009\u2013\u20099 and CA 72\u2009\u2013\u20094 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 22 (4), 2311\u20132316 (2002)."},{"issue":"10","key":"7665_CR8","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1093\/rheumatology\/keaa046","volume":"59","author":"X Bai","year":"2020","unstructured":"Bai, X. et al. Serum CA72-4 is specifically elevated in gout patients and predicts flares. Rheumatol. (Oxford). 59 (10), 2872\u20132880 (2020).","journal-title":"Rheumatol. (Oxford)"},{"key":"7665_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/bs.pmbts.2018.12.005","volume":"162","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Increased serum CA724 levels in patients suffering gout vs cancers. Prog Mol. Biol. Transl Sci. 162, 177\u2013186 (2019).","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"7665_CR10","doi-asserted-by":"publisher","first-page":"110611","DOI":"10.1016\/j.clinbiochem.2023.110611","volume":"118","author":"\u0130 Do\u011fan","year":"2023","unstructured":"Do\u011fan, \u0130. et al. 14-3-3 \u03b7 ETA protein as a potential marker of joint damage in gout. Clin. Biochem. 118, 110611 (2023).","journal-title":"Clin. Biochem."},{"issue":"6","key":"7665_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1532-5415.1968.tb01281.x","volume":"16","author":"ML Riccitelli","year":"1968","unstructured":"Riccitelli, M. L. Etiology and treatment of gout\u2013modern concepts. J. Am. Geriatr. Soc. 16 (6), 719\u2013728 (1968).","journal-title":"J. Am. Geriatr. Soc."},{"key":"7665_CR12","doi-asserted-by":"crossref","unstructured":"Trifir\u00f2, G. et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005\u20132009: a nationwide population-based study. Ann Rheum. Dis. 72 (5), 694\u2013700. (2005).","DOI":"10.1136\/annrheumdis-2011-201254"},{"key":"7665_CR13","unstructured":"Luk AJ, Epidemiology of hyperuricemia and gout. Am. J. Manag. Care 11 (15 Suppl), S435-42; quiz S465-8. (2013)."},{"issue":"2","key":"7665_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3109\/07357909509011692","volume":"13","author":"F Guadagni","year":"1995","unstructured":"Guadagni, F. et al. CA 72\u2009\u2013\u20094 serum marker\u2013a new tool in the management of carcinoma patients. Cancer Invest. 13 (2), 227\u2013238 (1995).","journal-title":"Cancer Invest."},{"key":"7665_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1196\/annals.1422.037","volume":"1108","author":"E Szekanecz","year":"2007","unstructured":"Szekanecz, E. et al. Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation? Ann. N Y Acad. Sci. 1108, 359\u2013371 (2007).","journal-title":"Ann. N Y Acad. Sci."},{"key":"7665_CR16","unstructured":"Balaban, Y. H. et al. Tumor markers in Familial mediterranean fever and their correlation with the frequency of attacks. Clin. Exp. Rheumatol. 26 (4 Suppl 50), S114\u2013S116. (2008)."},{"issue":"3","key":"7665_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5414\/CP201425","volume":"49","author":"C Okuda","year":"2011","unstructured":"Okuda, C. et al. Serum CRP in patients with gout and effects of benzbromarone. Int. J. Clin. Pharmacol. Ther. 49 (3), 191\u2013197 (2011).","journal-title":"Int. J. Clin. Pharmacol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07665-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07665-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07665-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:51:43Z","timestamp":1751381503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07665-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7665"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07665-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Second Afliated Hospital of Fujian Medical University (Date 2020\/No. 244). Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish it.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"20728"}}